- Home
- / Baudax Bio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Baudax Bio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.2
2024-07-18
Market Capitalization
$8.1 M
2024-07-18
Revenue
$1.3 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|
| Revenue | 493.0K | 1.1M | 1.3M | |
| Cost of goods sold | 1.7M | 2.4M | 7.0M | |
| Gross profit | (1.2M) | (5.7M) | ||
| Gross profit margin, % | -251.3% | -452.3% | ||
| General and administrative expense | 27.0M | 43.3M | 45.3M | 24.1M |
| Operating expense total | 47.1M | 73.5M | 17.6M | 51.1M |
| Depreciation and amortization | 2.1M | 2.6M | 2.0M | |
| EBIT | (32.5M) | (74.8M) | (19.0M) | (56.8M) |
| EBIT margin, % | -15169.6% | -4477.0% | ||
| Pre tax profit | (32.6M) | (76.1M) | (19.8M) | (58.8M) |
| Net Income | (32.6M) | (76.1M) | (19.8M) | (58.8M) |
| EPS | (177.3) |